CSS
XBI icon

Cubist Systematic Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cubist Systematic Strategies’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,100
Closed -$724K – 3618
2024
Q4 		$729K Buy
+8,100
New +$785K ﹤0.01% 1983
2024
Q3 		– Sell
-12,100
Closed -$1.19M – 3566
2024
Q2 		$1.12M Buy
+12,100
New +$1.08M 0.01% 1677

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cubist Systematic Strategies's XBI Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 8,100 shares — an estimated $724K sold.

Cubist Systematic Strategies first reported a position in XBI in Q2 2024 and held it in 2 quarters. The position peaked at $1.12M in Q2 2024. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 8,100 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $724K.
  • Cubist Systematic Strategies first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 2 quarters.
  • Cubist Systematic Strategies's State Street SPDR S&P Biotech ETF position peaked at $1.12M in Q2 2024.
  • 682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.